Clinical Trial Update: Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial comparing apixaban to warfarin for treatment of left ventricular thrombus after acute myocardial infarction, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus
• Myocardial Infarction

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Karolinska Institutet | Conditions: Left Ventricular Thrombus, Acute Myocardial Infarction | Phase 4 | Status: RECRUITING